Perceived Treatment Need and Latent Transitions in Heroin and Methamphetamine Polydrug Use among People who Inject Drugs in Tijuana, Mexico

References

• Bazzi, A. R., J. L. Syvertsen, M. L. Rolón, G. Martinez, G. Rangel, A. Vera, H. Amaro, M. D. Ulibarri, D. O. Hernandez, and S. A. Strathdee. 2016. Social and structural challenges to drug cessation among couples in Northern Mexico: Implications for drug treatment in underserved communities. Journal of Substance Abuse Treatment 61:26–33. doi:10.1016/j.jsat.2015.08.007.
   PubMed Web of Science ®Google Scholar
• Brecht, M.-L., D. Huang, E. Evans, and Y.-I. Hser. 2008. Polydrug use and implications for longitudinal research: Ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence 96 (3):193–201. doi:10.1016/j.drugalcdep.2008.01.021.
   PubMed Web of Science ®Google Scholar
• Brouwer, K. C., P. Case, R. Ramos, C. Magis-Rodriguez, J. Bucardo, T. L. Patterson, and S. A. Strathdee. 2006. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use & Misuse 41:707–21. doi:10.1080/10826080500411478.
   PubMed Web of Science ®Google Scholar
• Bucardo, J., K. C. Brouwer, C. Magis-Rodriguez, M. Fraga, S. G. Perez, T. L. Patterson, and S. A. Strathdee. 2005. Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections. Drug and Alcohol Dependence 79:281–93. doi:10.1016/j.drugalcdep.2005.02.003.
   PubMed Web of Science ®Google Scholar
• Coffin, P. O., S. Galea, J. Ahern, A. C. Leon, D. Vlahov, and K. Tardiff. 2003. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction 98 (6):739–47. doi:10.1046/j.1360-0443.2003.00376.x.
   PubMed Web of Science ®Google Scholar
• Collins, L., and S. Lanza. 2010. Latent class and latent transition analysis. Hoboken, NJ: Wiley.
   Google Scholar
• Cosden, M., J. L. Larsen, M. T. Donahue, and K. Nylund-Gibson. 2015. Trauma symptoms for men and women in substance abuse treatment: A latent transition analysis. Journal of Substance Abuse Treatment 50:18–25. doi:10.1016/j.jsat.2014.09.004.
   PubMed Web of Science ®Google Scholar
• Courtney, K. E., and L. A. Ray. 2014. Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence 143:11–21. doi:10.1016/j.drugalcdep.2014.08.003.
   PubMed Web of Science ®Google Scholar
• Dong, Y., and C.-Y. J. Peng. 2013. Principled missing data methods for researchers. SpringerPlus 2 (1):1. doi:10.1186/2193-1801-2-222.
   PubMed Web of Science ®Google Scholar
• Frost, S. D. W., K. C. Brouwer, M. A. F. Cruz, R. Ramos, M. E. Ramos, R. M. Lozada, C. Magis-Rodriguez, and S. A. Strathdee. 2006. Respondent-driven sampling of injection drug users in two US–Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health 83 (1):83–97. doi:10.1007/s11524-006-9104-z.
   Web of Science ®Google Scholar
• Garcia, A. 2015. Serenity: Violence, inequality, and recovery on the edge of Mexico City. Medical Anthropology Quarterly 29 (4):455–72. doi:10.1111/maq.12208.
   PubMed Web of Science ®Google Scholar
• Green, T. C., R. N. Bluthenthal, M. Singer, L. Beletsky, L. E. Grau, P. Marshall, and R. Heimer. 2010. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies. Drug and Alcohol Dependence 111 (1):74–81. doi:10.1016/j.drugalcdep.2010.03.022.
   PubMed Web of Science ®Google Scholar
• Grella, C. E., and K. Lovinger. 2011. 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug and Alcohol Dependence 118 (2):251–58. doi:10.1016/j.drugalcdep.2011.04.004.
   PubMed Web of Science ®Google Scholar
• Harrell, P. T., B. Mancha, H. Petras, R. Trenz, and W. W. Latimer. 2012. Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug and Alcohol Dependence 122 (3):220–27. doi:10.1016/j.drugalcdep.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Harvey-Vera, A. Y., P. González-Zúñiga, Magis-Rodríguez, K. Wagner, S. A. Strathdee, and D. Werb. 2016. Risk of violence in drug rehabilitation centers: Perceptions of people who inject drugs in Tijuana, Mexico. Substance Abuse Treatment, Prevention, and Policy 11 (1):1. doi:10.1186/s13011-015-0044-z.
   PubMed Web of Science ®Google Scholar
• Horigian, V. E., P. S. Espinal, E. Alonso, R. E. Verdeja, R. Duan, I. M. Usaga, A. Pérez-López, R. Marín-Navarrete, and D. J. Feaster. 2016. Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico. Salud Mental 39 (2):77–84. doi:10.17711/SM.0185-3325.2016.004.
   Web of Science ®Google Scholar
• Hser, Y.-I., D. Longshore, and M. D. Anglin. 2007. The life course perspective on drug use: A conceptual framework for understanding drug use trajectories. Evaluation Review 31 (6):515–47. doi:10.1177/0193841x07307316.
   PubMed Web of Science ®Google Scholar
• Hser, Y.-I., E. Evans, D. Huang, M.-L. Brecht, and L. Libo. 2008a. Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addictive Behaviors 33 (12):1581–89. doi:10.1016/j.addbeh.2008.07.024.
   PubMed Web of Science ®Google Scholar
• Hser, Y.-I., D. Huang, M.-L. Brecht, L. Libo, and E. Evans. 2008b. Contrasting trajectories of heroin, cocaine, and methamphetamine use. Journal of Addictive Diseases 27 (3):13–21. doi:10.1080/10550880802122554.
   PubMed Web of Science ®Google Scholar
• Hunt, N., M. Trace, and M. Bewley-Taylor. 2003. Reducing drug related harms to health: An overview of the global evidence. Oxford, UK: The Beckley Foundation Drug Policy Programme.
   Google Scholar
• IPEBC. 2014. Encuesta de detección de consumo de sustancias psicoactivas en el estado durante el 2013. Mexicali, Mexico: Instituto de Psiquiatría del Estado de Baja California, Observatorio Estatal Adicciones.
   Google Scholar
• Lanza, S. T., and B. C. Bray. 2010. Transitions in drug use among high risk women: An application of latent class and latent transition analysis. Advanced Applications in Statistical Science 3 (2):203–35.
   PubMedGoogle Scholar
• Lanza, S. T., M. E. Patrick, and J. L. Maggs. 2010. Latent transition analysis: Benefits of a latent variable approach to modeling transitions in substance use. Journal of Drug Issues 40 (1):93–120. doi:10.1177/002204261004000106.
   PubMed Web of Science ®Google Scholar
• Lozano-Verduzco, I., R. Marín-Navarrete, M. Romero-Mendoza, and A. Tena-Suck. 2015. Experiences of power and violence in Mexican men attending mutual-aid residential centers for addiction treatment. American Journal of Men’s Health 10 (3): 1557988314565812.
   Web of Science ®Google Scholar
• Marín-Navarrete, R., L. Templos-Nuñez, A. Eliosa-Hernández, L. Villalobos-Gallegos, J. Fernández-Mondragón, A. Pérez-López, D. Galván-Sosa, R. E. Verdeja, E. Alonso, and D. J. Feaster. 2014. Characteristics of a treatment-seeking population in outpatient addiction treatment centers in Mexico. Substance Use & Misuse 49 (13):1784–94. doi:10.3109/10826084.2014.931972.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., D. C. Lewis, C. P. O’Brien, and H. D. Kleber. 2000. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA 284 (13):1689–95. doi:10.1001/jama.284.13.1689.
   PubMed Web of Science ®Google Scholar
• Meacham, M. C., S. C. Roesch, S. A. Strathdee, S. Lindsay, P. Gonzalez-Zuniga, and T. L. Gaines. 2017. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico. Drug and Alcohol Review. doi:10.1111/dar.12524.
   PubMed Web of Science ®Google Scholar
• Meacham, M. C., S. A. Strathdee, G. Rangel, R. F. Armenta, T. L. Gaines, and R. S. Garfein. 2016. Prevalence and correlates of heroin–methamphetamine co-injection among persons who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico. Journal of Studies on Alcohol and Drugs 77 (5):774–81. doi:10.15288/jsad.2016.77.774.
   PubMed Web of Science ®Google Scholar
• Mistry, R., J. E. Heinze, D. Cordova, H.-F. Heish, J. E. Goldstick, S. M. Ayer, and M. A. Zimmerman. 2015. Transitions in current substance use from adolescence to early-adulthood. Journal of Youth and Adolescence 44 (10):1871–83. doi:10.1007/s10964-015-0309-x.
   PubMed Web of Science ®Google Scholar
• Muthen, B. 2001. Latent variable mixture modeling. In New developments and techniques in structural equation modeling, eds. G. A. Marcoulides and R. E. Schumacker, 1–33. Hove, UK: Psychology Press.
   Google Scholar
• Muthén, B. O., and T. Asparouhov. 2011. LTA in Mplus: Transition probabilities influenced by covariates (Mplus Web Notes: No. 13). Los Angeles, CA: Muthén & Muthén.
   Google Scholar
• Muthén, L. K., and B. O. Muthén. 1998–2012. Mplus user’s guide, 7th ed. Los Angeles, CA: Muthén & Muthén.
   Google Scholar
• NIDA. 2016. Drug abuse and addiction. National Institute on Drug Abuse. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/drug-abuse-addiction.
   Google Scholar
• Nosyk, B., L. Li, E. Evans, D. Huang, J. Min, T. Kerr, M. L. Brecht, and Y. I. Hser. 2014. Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence 140:69–77. doi:10.1016/j.drugalcdep.2014.03.029.
   PubMed Web of Science ®Google Scholar
• Nutt, D., L. A. King, W. Saulsbury, and C. Blakemore. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet 369 (9566):1047–53. doi:10.1016/S0140-6736(07)60464-4.
   PubMed Web of Science ®Google Scholar
• Nylund, K. L. 2007. Latent transition analysis: Modeling extensions and an application to peer victimization. Los Angeles, CA: University of California Los Angeles.
   Google Scholar
• Prochaska, J. O., C. C. DiClemente, and J. C. Norcross. 1992. In search of how people change: Applications to addictive behaviors. American Psychologist 47 (9):1102–14. doi:10.1037/0003-066X.47.9.1102.
   PubMed Web of Science ®Google Scholar
• Radfar, S. R., and R. A. Rawson. 2014. Current research on methamphetamine: Epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addiction & Health 6 (3–4):146.
   PubMedGoogle Scholar
• Ramo, D. E., M. A. Prince, S. C. Roesch, and S. A. Brown. 2012. Variation in substance use relapse episodes among adolescents: A longitudinal investigation. Journal of Substance Abuse Treatment 43 (1):44–52. doi:10.1016/j.jsat.2011.10.003.
   PubMed Web of Science ®Google Scholar
• Robertson, A. M., R. S. Garfein, K. D. Wagner, S. R. Mehta, C. Magis-Rodriguez, J. Cuevas-Mota, P. G. Moreno-Zuniga, and S. A. Strathdee. 2014. Evaluating the impact of Mexico’s drug policy reforms on people who inject drugs in Tijuana, BC, Mexico, and San Diego, CA, United States: A binational mixed methods research agenda. Harm Reduction Journal 11 (1):4. doi:10.1186/1477-7517-11-4.
   PubMed Web of Science ®Google Scholar
• Rojas, E., T. Real, S. García-Silberman, and M. E. Medina-Mora. 2011. Revisión sistemática sobre tratamiento de adicciones en México. Salud Mental 34 (4):351–65.
   Google Scholar
• Shin, Y., J.-K. Lee, Y. Lu, and M. L. Hecht. 2015. Exploring parental influence on the progression of alcohol use in Mexican-heritage youth: A latent transition analysis. Prevention Science 17 (2): 1–11.
   Web of Science ®Google Scholar
• Sifaneck, S. J., and C. D. Kaplan. 1995. Keeping off, stepping on and stepping off: The steppingstone theory reevaluated in the context of the Dutch cannabis experience. Contemporary Drug Problems 22:483–512. doi:10.1177/009145099502200306.
   Google Scholar
• Smith, G. W., M. Farrell, B. P. Bunting, J. E. Houstona, and M. Shevlin. 2011. Patterns of polydrug use in Great Britain: Findings from a national household population survey. Drug and Alcohol Dependence 113:222–28. doi:10.1016/j.drugalcdep.2010.08.010.
   PubMed Web of Science ®Google Scholar
• Strang, J., J. Bearn, M. Farrell, E. Finch, M. Gossop, P. Griffiths, J. Marsden, and K. Wolff. 1998. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug and Alcohol Review 17 (2):197–211. doi:10.1080/09595239800187001.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., R. Lozada, R. A. Pollini, K. C. Brouwer, A. Mantsios, D. A. Abramovitz, T. Rhodes, C. A. Latkin, O. Loza, and J. Alvelais. 2008. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Journal of Acquired Immune Deficiency Syndromes 47 (3):369. doi:10.1097/QAI.0b013e318160d5ae.
   PubMed Web of Science ®Google Scholar
• Syvertsen, J., R. A. Pollini, R. Lozada, A. Vera, G. Rangel, and S. A. Strathdee. 2010. Managing la malilla: Exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform. International Journal of Drug Policy 21 (6):459–65. doi:10.1016/j.drugpo.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Watters, J. K., and P. Biernacki. 1989. Targeted sampling: Options for the study of hidden populations. Social Problems 36 (4):416–30. doi:10.2307/800824.
   Web of Science ®Google Scholar
• WHO. 2014. Mental health atlas country profiles. Geneva, Switzerland: World Health Organization. http://www.who.int/mental_health/evidence/atlas/profiles-2014/mex.pdf.
   Google Scholar